Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Lung Neoplasms 6Breast Neoplasms 6Carcinoma, Non-Small-Cell Lung 5Uterine Cervical Neoplasms 3Pancreatic Neoplasms 3Lymphoma, Non-Hodgkin 3Lymphoma 3Urinary Bladder Neoplasms 2Nasopharyngeal Carcinoma 2Hodgkin Disease 2Gallbladder Neoplasms 2Cholangiocarcinoma 2Triple Negative Breast Neoplasms 1Testicular Neoplasms 1Small Cell Lung Carcinoma 1Renal Insufficiency 1Neoplastic Cells, Circulating 1Locally Advanced Cervical Cancer 1Fibrosis Of Extraocular Muscles, Congenital, 3A, with or without Extraocular Involvement 1Carcinoma, Transitional Cell 1

Interventions

Paclitaxel 1Gemcitabine 1Doxorubicin 1Cyclophosphamide 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Fibrosis Of Extraocular Muscles, Congenital, 3A, with or without Extraocular Involvement × Gemcitabine × Clear all
NCT06531447 2024-08-01

First-line Gemcitabine Plus Cisplatin in Locally Advanced (IIIC Stage) Breast Cancer Patients

The National Center of Oncology, Azerbaijan

Phase 2 Active not recruiting
200 enrolled
Breast

Fibrosis Of Extraocular Muscles, Congenital, 3A, with or without Extraocular Involvement, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡